SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 4152.
  • 2
    Quinn ER, Chan CH, Hadlock KG, Foung SKH, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 37459.
  • 3
    De Re V, De Vita S, Marzotto A, Gloghini A, Pivetta B, Gasparotto D, Cannizzaro R, Carbone A, Boiocchi M. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 2000; 87: 2116.
  • 4
    Vallisa D, Bertè R, Rocca A, Civardi G, Giangregorio F, Ferrari B, Sbolli G, Cavanna L. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histological subtype and clinical course. Am J Med 1999; 106: 55660.
  • 5
    Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortulus R, Crovatto M, Santini G, Tiribelli C, Sasso F, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 54450.
  • 6
    Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296301.
  • 7
    Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochaiani E, Mazzoni A, Mazzaro C, Pasero G. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 3924.
  • 8
    Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong T-L. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 4238.
  • 9
    Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 9969.
  • 10
    Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 125961.
  • 11
    Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky J, Dhumeaux D, Reyes F. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999; 93: 177883.
  • 12
    Shariff S, Yoshida EM, Gascoyne RD, Le N, Connors JM, Middleton PJ, Shenkier TN. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncology 1999; 10: 9614.
  • 13
    Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, van den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 42402.
  • 14
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26: 62S5S.
  • 15
    Paydas S, Kilic B, Sahin B, Bugdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 1999; 80: 13035.
  • 16
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 Aug 19; 341: 55662.
  • 17
    International classification of diseases for oncology, second ed. Geneva: World Health Organization, 1990.
  • 18
    Lee Harris N, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan, TM, Isaacson PG, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 136192.
  • 19
    Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C, HEPATITS Group. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 2001; 8: 8795.
  • 20
    Pathology and genetics of tumours of haematopoietic and lymphoid tissues. JaffeES, Lee HarrisN, SteinH, VardimanJW, eds. Lyon: IARC Press, 2001.
  • 21
    Terrault NA, Wright TL, Pereira BJ. Hepatitis C infection in the transplant recipient. Infect Dis Clinics North Am 1995; 9: 94364.
  • 22
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall, 1993.
  • 23
    Edington ES. Randomized tests, second ed. New York: Dekker, 1987.
  • 24
    Rothman KJ, Greenland S. Case-control studies. In: RothmanKJ, GreenlandS, eds. Modern epidemiology, second ed. Philadelphia: Lippincott-Raven, 1998. 93114.
  • 25
    Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P, Corbishley T. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 6214.
  • 26
    Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G, Zanetti A. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 5737.
  • 27
    Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, Caini P, La Villa G, Laffi G, Gentililni P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 4749.
  • 28
    Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe JM. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 15559.
  • 29
    Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TSB, Lindsay KL, Levine AM, Lai MMC. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 213446.
  • 30
    Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 93841.
  • 31
    Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002 Jul 11; 347: 8994.
  • 32
    Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Morb Mortal Wkly Rep 1991; 40: 117.
  • 33
    Cerhan JR, Wallace RB, Dick F, Kemp J, Parker AS, Zheng W, Sellers TA, Folsom AR. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidiol Biomarkers Prev 2001; 10: 3618.
  • 34
    Coté TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Goedert JJ, Blattner WA. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer 1997; 73: 64550.